INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 April 2015
|
Net Assets |
£234m |
|
Net Assets per share |
572p |
|
Share price |
512p |
|
Total value of unquoted investments |
£18m |
|
Total number of portfolio companies |
83 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Amgen |
7.6 |
|
Gilead |
7.5 |
|
Biogen |
6.9 |
|
Celgene |
6.8 |
|
Regeneron |
6.4 |
|
Alexion |
4.7 |
|
Mylan |
3.9 |
|
Vertex |
3.5 |
|
Entellus |
3.1 |
|
Biomarin |
2.9 |
|
|
----------- |
|
Total |
53.3 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
56 |
|
Turning Profitable 2015 |
7 |
|
Unprofitable |
37 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
90 |
|
Europe & UK |
10 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
92 |
|
Unquoted |
8 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
28 MAY 2015